Skip to main navigation
Logo
Investors

Events and Presentations

Events and Presentations

  • Events
  • Presentations
DateTitle
December 14, 2020
Investor presentation – December 14, 2020 2.4 MB
December 14, 2020
Complement R&D Day Presentation 4.9 MB
December 07, 2020
ASH – Crimson 1 Study: Phase 3 study to evaluate the efficacy and safety of subcutaneous marzeptacog alfa (activated) for on-demand treatment and control of bleeding episodes in subjects with hemophilia A or hemophilia B, with inhibitors 331.2 KB
November 24, 2020
Piper Sandler Virtual Healthcare Conference Presentation 1.9 MB
July 13, 2020
ISTH – Marzeptacog alfa (activated) population pharmacokinetics (PK): Simulations for dose selection in Phase 3 trials 2.1 MB
July 13, 2020
ISTH – Phase 1 study to evaluate the pharmacokinetics, pharmacodynamics, and safety of ascending doses of subcutaneous marzeptacog alfa (activated) in adult subjects with hemophilia 1 MB
June 19, 2020
WFH - Combination of a Novel Chimeric AAV Capsid and Potency Enhanced FIX Variant for Hemophilia B Gene Therapy 2 MB
June 15, 2020
WFH - Phase 2B Trial to Evaluate the Safety and Factor IX Levels of a Daily Subcutaneous Prophylaxis Treatment Regimen of Dalcinonacogalfa in Hemophilia B 2.1 MB

Shareholder Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts

Investor Relations

  • Overview
  • Press Releases
  • Events and Presentations
    • Scientific Presentations and Publications
  • Financials & Filings
  • Stock Information
  • Corporate Governance
  • Investor FAQ
  • Contact Us

Shareholder Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • About
    • Management Team
    • Board of Directors
    • Strategic Partners
    • Contact Us
  • Pipeline
    • Hemostasis
    • Anti-Complement
  • Science
  • News
  • Investors

    Investor header menu

    • Press Releases
    • Events and Presentations
    • Financials & Filings
    • Stock Information
      • Stock Quote
      • Stock Chart
    • Corporate Governance
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor FAQ
    • Contact Us
  • Careers
  • Home
  • Contact
  • Home
  • Contact
  • About
    • Management Team
    • Board of Directors
    • Strategic Partners
    • Contact Us
  • Pipeline
    • Hemostasis
    • Anti-Complement
  • Science
  • News
  • Investors
    • Press Releases
    • Events and Presentations
    • Financials & Filings
    • Stock Information
      • Stock Quote
      • Stock Chart
    • Corporate Governance
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor FAQ
    • Contact Us
  • Careers
    • Benefits
  • Terms of Use
  • Privacy Policy
  • LinkedIn
© 2021 Catalyst BiosciencesAll rights reservedWebsite Design: Hane Chow, Inc.
  • Terms of Use
  • Privacy Policy
  • LinkedIn
  • Twitter
  • Facebook